Stock screener

CMPS

Conviction 80HealthcareScan · Mon, Aug 10, 2026
CMPS$13.19-2.62%
ResistanceSupportVol 14
63 bars
Vol MA14 2.94M
May 11May 28Jun 16Jul 6Jul 23Aug 10
COMPASS Pathways plcPHARMACEUTICAL PREPARATIONScompasspathways.com
Price13.19
Change-2.62%
Gap+0.22%
Rel volume0.52×
Avg volume3.74M
Avg $ vol46.08M
SMA 2012.15
SMA 5012.59
SMA 2008.42
Price vs 50+4.75%
Price vs 200+56.61%
MA stackbullish
50/200 cross
Supertrendup · 11.14
RSI (14)57
MACD hist0.23
MACD crossbull · 3d
Stoch %K / %D74 / 84
ADX (14)18
+DI / −DI30 / 17
RSI divergence
MACD divergence
ATR %+6.36%
ADR %6.57%
52w high15.07
52w low4.08
From 52w high-12.51%
Above 52w low+223.16%
New 52w highNo
SqueezeOff
Bollinger width30.53%
%B0.78
Donchian pos64.71%
Donchian high14.60
Donchian low10.59
AVWAP (52w high)12.79
vs AVWAP high+3.06%
AVWAP (52w low)8.96
vs AVWAP low+47.11%
OBV trendDown
Chaikin MF (20)-0.14
Today vs 20d0.52×
Avg vol (14d)2.94M
Avg vol (20d)3.74M
Avg $ vol (20d)46.08M
Market cap1.83B
RS 3m (vs SPY)+38.50%
RS 6m (vs SPY)+123.01%
RS line new highNo
Trend template8/8
Technical rank78.2
1 week+17.20%
1 month-3.34%
3 months+33.05%
6 months+113.00%
1 year+205.92%
YTD+101.30%
P/E-6.34
P/B21.60
P/S
P/FCF-11.61
EPS-3.08
Div yield
ROE-340.53%
ROA-57.05%
Debt/Eq0.60
Current1.30
EV/EBITDA-8.07
Gross margin
Net margin
Rev growth
EPS growth-85.57%
Price target23.67
Target upside79.52%
Analyst ratingBuy
Institutional69.84%
Ent. value1.44B
Revenue
Net income-253.79M
Gross profit
Free cash flow-157.24M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out134.95M
Employees156
ListedFri, Sep 18, 2020
Free float19.5M
Float %14.1%
Short interest12.84M
Days to cover2.6d
Short volume25.0%
Squeeze score53 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.36 vs −$0.46
Last surprise+21.7% beat
Setup gradeA
Conviction80 / 100
Pattern quality
Tech rank78.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance15.00
Support10.87
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CMPS

All disclosures →
No recent disclosed trades by Congress in CMPS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CMPS · 8 buys · 1 sell

InsiderSideShares
Nath Kabir
Chief Executive Officer · Ordinary Shares · 2026-08-03
Tax5.96K
Riley Wayne Joseph
Director · Share Option (Right to Buy) · 2026-05-27
Grant21.11K
Tregoning Kathleen
Director · Share Option (Right to Buy) · 2026-05-27
Grant41.12K
JONAS JEFFREY M
Director · Share Option (Right to Buy) · 2026-05-27
Grant21.11K
Gover Justin D.
Director · Share Option (Right to Buy) · 2026-05-27
Grant21.11K
Norton David Y
Director · Share Option (Right to Buy) · 2026-05-27
Grant21.11K
McQuade Robert
Director · Share Option (Right to Buy) · 2026-05-27
Grant21.11K
SANTINI GINO
Director · Share Option (Right to Buy) · 2026-05-27
Grant30.16K
Karydas Daphne
Director · Share Option (Right to Buy) · 2026-05-27
Grant21.11K

SEC filings

EDGAR filings in CMPS · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.